Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Holler

Showing results (201-210 of 265) with videos related to

Pageof 27
Sort By:
JMIR Formative Research|January 7, 2022
Assessing COVID-19 Health Information on Google Using the Quality Evaluation Scoring Tool (QUEST): Cross-sectional and Readability AnalysisVismaya S Bachu, Heba Mahjoub, Albert E Holler, et al.
European Journal of Medical Research|October 1, 1998
Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot studyP Neumeister, E Hiller, M Gawaz, et al.
Blood|June 15, 1992
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host diseaseP Hervé, M Flesch, P Tiberghien, et al.
Annals of Hematology|July 1, 1991
Functional characterization of canine lymphocyte subsetsC Hötzl, H J Kolb, E Holler, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 15, 2011
Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challengesN A Kittan, F Beier, K Kurz, et al.
Experimental Hematology|November 1, 1984
Serological identification and separation of canine lymphocyte subpopulationsE Holler, H J Kolb, U Bodenberger, et al.
Bone Marrow Transplantation|August 5, 2014
Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysisS Mielke, M Lutz, J Schmidhuber, et al.
Cancer Treatment Reviews|September 1, 1990
Platinum compounds with estrogen receptor affinityP J Bednarski, R Gust, T Spruss, et al.
Bone Marrow Transplantation|March 1, 1997
Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantationC Salat, E Holler, C Wolf, et al.
Annals of Hematology|October 1, 1991
Immunological characterization of canine hematopoietic progenitor cellsJ Hahn, H J Kolb, M Schumm, et al.
Pageof 27

Showing results (201-210 of 265) with videos related to

Sort By:
Pageof 27
JMIR Formative Research|January 7, 2022
Assessing COVID-19 Health Information on Google Using the Quality Evaluation Scoring Tool (QUEST): Cross-sectional and Readability AnalysisVismaya S Bachu, Heba Mahjoub, Albert E Holler, et al.
European Journal of Medical Research|October 1, 1998
Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot studyP Neumeister, E Hiller, M Gawaz, et al.
Blood|June 15, 1992
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host diseaseP Hervé, M Flesch, P Tiberghien, et al.
Annals of Hematology|July 1, 1991
Functional characterization of canine lymphocyte subsetsC Hötzl, H J Kolb, E Holler, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 15, 2011
Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challengesN A Kittan, F Beier, K Kurz, et al.
Experimental Hematology|November 1, 1984
Serological identification and separation of canine lymphocyte subpopulationsE Holler, H J Kolb, U Bodenberger, et al.
Bone Marrow Transplantation|August 5, 2014
Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysisS Mielke, M Lutz, J Schmidhuber, et al.
Cancer Treatment Reviews|September 1, 1990
Platinum compounds with estrogen receptor affinityP J Bednarski, R Gust, T Spruss, et al.
Bone Marrow Transplantation|March 1, 1997
Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantationC Salat, E Holler, C Wolf, et al.
Annals of Hematology|October 1, 1991
Immunological characterization of canine hematopoietic progenitor cellsJ Hahn, H J Kolb, M Schumm, et al.
Pageof 27